Is the iPad a medical device?

Last Updated on

September 03, 2016 – This morning, I stumbled upon the headline of a posting on mobihealthnews, entitled “Study finds iPads and games as effective as sedatives to calm pre-op anxiety in children” and starting out with saying “The hypnotic trance kids enter when they’re staring at an iPad isn’t just for on-demand quiet time in restaurants or

iPad as a sedative for kids before surgery?

iPad as a sedative for kids before surgery?

cars. Turns out, the smart tablets are so effective at zoning out kids, they work just as well as sedatives to quell anxiety before surgery“. This posting caught my attention immediately for at least two reasons.

First, for parents like myself, it would be very reassuring if, before any surgery, in effect you would not have to calm your child with any kind of medication but instead let them play, on their mobile yet smart device. Secondly, the posting points in the direction that in fact iPads (most probably, for that matter, any smart mobile device of today or of the future) might actually be approvable as a medical device. So, what would then qualify as a medical device? The definition by the American Food & Drug Administration (FDA) for medical device says that a medical device is “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is:

  • recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them,
  • intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or
  • intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.”

When you read the posting below, then it becomes clear that in the cited study, iPad had just the effect to “affect a function of the body (control of anxiety level) and doing so without chemical action within or on the body”. Bingo. As of yet, I would not want to speculate about the changes in the market place and pricing scheme for both, devices and medications, if in fact mobile smart devices should one day in the future become approvable as medical devices.

In the meantime, we may rest with taking note of the study by a group of French doctors, led by Dr. Dominique Chassard of Hopital Mere Enfant, Hospices Civils de Lyon, presented a poster at the World Congress of Anesthesiologists in Hong Kong that compared the use midazolam, a conventional sedative, to that of iPads loaded with age-appropriate game apps on 112 children aged 4 to 10 years old during and after ambulatory surgery. The children were randomly divided into two groups, with each group receiving either the midazolam or iPad 20 minutes before anesthesia. Child anxiety was measured (using m-YPAS scoring, a standardized assessment tool), by two independent psychologists at four time points: arrival at the hospital, separation from parents, during anesthesia induction and post anesthesia care unit. A half an hour after the child received their last dose of anesthesia, they were transferred to the ambulatory surgery ward. Parents were also assessed for anxiety during the arrival, separation and in the post-surgery unit.

The researchers found anxiety levels to be similar in both groups. The team has not published a full paper yet, but the poster referenced a 2006 study showing similar outcomes when using mobile devices as a means of distraction before pediatric operations.

“Our study showed that child and parental anxiety before anaesthesia are equally blunted by midazolam or use of the iPad,” Chassard concluded in the poster.

What’s more, the parents prefer to trade drugs for the mobile interactive tool to the sedative, and nurses found the anesthesia induction quality was higher with the iPad group. “… the quality of induction of anesthesia, as well as parental satisfaction, were judged better in the iPad group,” wrote Chassard. “Use of iPads or other tablet devices is a non-pharmacologic tool which can reduce perioperative stress without any sedative effect in pediatric ambulatory surgery.”

Tags: , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login

Notify of

[…] In this context, it is even imaginable that smart devices may become medical devices, as already briefly discussed by thasso in the case of iPad’s use as sedatives for kids in pre-surgery […]

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Scientists use gene-editing tool CRISPR in attempt to cure HIV September 13, 2019
    The first attempt to use the gene-editing tool CRISPR to cure HIV infection was unsuccessful but the approach does show promise.
  • New cardiac fibrosis study identifies key proteins that translate into heart disease September 12, 2019
    Using cutting-edge technologies, researchers at Duke-NUS Medical School, Singapore, have developed the first genome-wide dataset on protein translation during fibroblast activation, revealing a network of RNA-binding proteins (RBPs) that play a key role in the formation of disease-causing fibrous tissue in the heart. Their findings, published in the journal Circulation, could help in the search […]
  • How your genes affect the number on your scale September 12, 2019
    Could your genes be keeping you from losing weight?
  • Scientists identify gene as master regulator in schizophrenia September 11, 2019
    Using computational tools to investigate gene transcription networks in large collections of brain tissues, a scientific team has identified a gene that acts as a master regulator of schizophrenia during early human brain development. The findings may lay the groundwork for future treatments for the highly complex neuropsychiatric disorder.
  • How your DNA takes shape makes a big difference in your health September 11, 2019
    The more we learn about our genome, the more mysteries arise. For example, how can people with the same disease-causing mutation have different disease progression and symptoms? And despite the fact that it's been more than 15 years since the human genome was sequenced, why can't we explain the significance of the vast majority of […]